Interleukin-6 Receptor Antagonist
6 drugs across 3 manufacturers|0 Generic,6 Brand
The Interleukin-6 Receptor Antagonist class contains 6 NDCs from 3 manufacturers (0 generic, 6 brand), at an average NADAC of $1344.18 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
6
0G / 6B
Manufacturers
3
Avg $1344.1781/unit
Avg 7d Change
-0.06%
Across 3 drugs with changes
7d Activity
of 6 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Interleukin-6 Receptor Antagonist class?
The Interleukin-6 Receptor Antagonist class contains 6 NDCs from 3 manufacturers — 0 generic and 6 brand products.
What is the average price of Interleukin-6 Receptor Antagonist drugs?
The average NADAC for the Interleukin-6 Receptor Antagonist class is $1344.1781 per unit across 6 NDCs.
Which manufacturers make Interleukin-6 Receptor Antagonist drugs?
3 manufacturers make drugs in the Interleukin-6 Receptor Antagonist class. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (2), Genentech, Inc. (2), Fresenius Kabi USA, LLC (2).
How has Interleukin-6 Receptor Antagonist pricing changed recently?
Over the past 7 days, 2 NDCs in this class rose and 1 fell, with a class-wide average change of -0.1%.
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KEVZARA 200 MG/1.14 ML PEN INJ sarilumab | $2077.0932 per ML | -0.24% |
KEVZARA 200 MG/1.14 ML SYRINGE sarilumab | $2066.4821 per ML | — |
ACTEMRA ACTPEN 162 MG/0.9 ML tocilizumab | $1279.0578 per ML | — |
ACTEMRA 162 MG/0.9 ML SYRINGE tocilizumab | $1001.1205 per ML | — |
TYENNE 162 MG/0.9 ML AUTOINJCT Tocilizumab-aazg | $820.6574 per ML | +0.13% |
TYENNE 162 MG/0.9 ML AUTOINJCT Tocilizumab-aazg | $820.6574 per ML | +0.13% |